Cencora delivered solid financial performance in Q3 2025 with higher revenue, EPS, and net income. Growth was fueled by strength in U.S. operations and benefits from recent acquisitions.
Revenue reached $80.7 billion, up from $74.2 billion a year ago.
GAAP EPS was $3.52; Adjusted EPS rose to $4.00.
Net income attributable to Cencora increased to $687 million.
The company raised FY25 adjusted EPS guidance to $15.85β$16.00.
Cencora raised its fiscal 2025 guidance, citing strong earnings growth from the U.S. Healthcare Solutions segment.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance